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EpiTYPER® is a mass spectrometry-based bisulfite sequencing method that enables
region-specific DNA methylation analysis in a quantitative and high-throughput fashion.
The technology targets genomic regions of 100–600 base pairs and results in
the quantitative measurement of DNA methylation levels largely at single-nucleotide
resolution. It is particularly suitable for larger scale efforts to study candidate regions
or to validate regions from genome-wide DNA methylation studies. Here, we describe in
detail how to design and perform EpiTYPER measurements and preprocess the data,
providing details for high quality measurements not provided in the standard EpiTYPER
protocol.
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Introduction
EpiTYPER R© (Ehrich et al., 2005) is a technology to quantitatively assess DNA methylation of
multiple CpGs in genomic regions of 100–600 base-pairs. EpiTYPER R© uses the Agena Bioscience
(previously Sequenom Inc.) MassArray R© set-up which has a high degree of automation and
sufficient throughput for the larger scale evaluation of candidate regions. EpiTYPER has been
successfully used for candidate gene studies in many fields, including in studies on cancer (Radpour
et al., 2009), development (Loke et al., 2013), and nutrition (do Amaral et al., 2014). Another major
application is in the validation of regions identified in various genome-wide DNA methylation
assays (Christensen et al., 2010; Figueroa et al., 2010; Popp et al., 2010; Zeilinger et al., 2013; Tobi
et al., 2014) or follow-up of findings from such studies in thousands of additional samples (Zhang
et al., 2014).
The good quantitative accuracy of the technology has been used to detect DNA methylation
differences between conditions down to a few percent points depending on the sample size (Tobi
et al., 2012). EpiTYPER is particularly useful for projects that require the measurement of larger
numbers of samples or regions since a single EpiTYPER run yields 126 triplicate measurements.
Including required controls, it entails an experiment on a 384-well PCR plate. The set-up is flexible
in the number of samples and regions that are combined in a run. The method is, however, not
cost-effective for projects entailing less than 126 triplicate measurements.
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The principle of EpiTYPER is mass based re-sequencing of
PCR amplified bisulfite converted DNAwith amass spectrometer
and involves several biochemical steps (Figure 1) (Ehrich et al.,
2005, 2007). In short, genomic DNA (gDNA) is treated with
bisulfite which leads to a conversion of all unmethylated
cytosines, while methylated cytosines remain unaffected. A PCR
is performed on the bisulfite converted DNA with primers
tagged with a T7 promoter. After shrimp alkaline phosphatase
treatment, to discard unincorporated DNA nucleotides, the T7
promoter added during PCR is used to transcribe the PCR
product from the reverse strand, yielding a single stranded
RNA product. This RNA product is cleaved with RNase A
resulting in a specific fragmentation of the RNA product. After
a final cleaning step with a resin the samples are loaded on
a SpectroCHIP R© II Array, which prepares the fragments for
separation on mass with the mass spectrometer. The mass
spectrometer is a Matrix Assisted Laser Desorption-Ionization
Time of Flight (MALDI-TOF) device. The matrix on the
SpectroCHIP II absorbs the energy of the laser and transfers
it to the RNA fragments which subsequently become ionized.
The ionized fragments are separated by the time it takes to
arrive at the detector in at the end of the mass spectrometer’s
flight tube under the influence of an electric field. The time
of flight increases with higher mass. A fragment containing
one or more CpG dinucleotides is called a CpG unit. If a
CpG dinucleotide was methylated and protected from bisulfite
conversion, the corresponding RNA fragment, the CpG unit,
will be 16Da heavier in mass when the CpG dinucleotide was
methylated, resulting in a 16Da shift in the mass spectrum. The
FIGURE 1 | Biochemical steps and methylation quantification with EpiTYPER®. EpiTYPER® resolves on re-sequencing DNA on mass. After bisulfite
conversion DNA is amplified by PCR and the resulting PCR product is transcribed from the reverse strand of the PCR product. This single stranded product is cleaved
after each T resulting in fragments of known mass. Fragments with a methylated cytosine are 16 Dalton heavier than fragments with a non-methylated cytosine, the
size of the two peaks can be used to calculate the methylation ratio of the CpG dinucleotide. It is easy to envision that fragments can arise with the same mass or with
a mass extremely close to that of another fragment. Such circumstances limit the detection of certain CpG dinucleotides.
signal detected by the mass spectrometer for either fragments
is proportional to the number of fragments. The number of
fragments is quantified by the surface area of the corresponding
peaks in the mass spectrum. The DNA methylation percentage
of a given CpG is calculated by dividing the surface area of the
peak representing the methylated fragment by the total surface
area of the peaks of both the methylated and unmethylated
fragment.
For an effective application of EpiTYPER, a streamlined
process of assay design, assay validation, bisulfite conversion,
data generation, and data processing is necessary. These steps
involve switching between lab and computer work. We will
provide a step-wise description of all these steps and also include
various tips. These steps are an addition to the protocol provided
for EpiTYPER by Agena Biosciences.
Materials and Equipment
Prerequisites
Agena Bioscience Inc. provides several automated pipelines for
the measurement of nucleotides (SNPs, gene-expression etc.) on
the MassARRAY R© system. If a MassARRAY system is already
available EpiTYPER only requires an additional proprietary
software suite, and some additional fine-tuning of the MALDI-
TOF mass spectrometer by a specialized service engineer to
function. If a MassARRAY system is not yet available EpiTYPER
will require a significant investment in hardware, including
a compatible provided MALDI-TOF mass spectrometer, an
automated liquid handling system to transfer samples from 384
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plates to the SpectroCHIP II and a dedicated server to process
and store the data generated.
Consumables
Bisulfite Conversion
1. EZ-96 DNA methylation kit, Shallow-Well Format (ZYMO
Research) or for less samples the EZ DNA methylation kit
(ZYMO Research). For a large number of samples we advise
to use the 96-well format to reduce the number of batches in
the experiment.
2. Tris base (ROCHE).
3. Ethanol absolute (molecular biology grade).
EpiTYPER
4. Ethylenediaminetetraacetic acid disodium salt dihydrate
(Sigma-Aldrich).
5. Thermo-Fast 384 PCR Plates (Westburg), or plastics
appropriate for your PCR set-up.
6. SpectroCHIP R© II Array and Clean Resin Kit (Agena
Bioscience Inc).
7. MassCLEAVE™, T Cleavage Kit (Agena Bioscience Inc).
8. Hotstar taq DNA polymerase (Qiagen, including buffer).
9. dNTP mix, PCR grade (Qiagen; 10mM of each nucleotide).
Solutions to Prepare
1. 1M Tris-HCl pH7.5 (1L): add 141.1 g Tris base to 800ml
ddH20, adjust pH by adding approximately 60ml of HCl and
sterilize.
2. 5.0mM Tris pH7.5 (1L): 5ml 1M Tris-HCl pH7.5 (or pH8.0
depending on the subsequent step), add ddH2O to 1L and
sterilize.
3. 0.5M EDTA pH8.0 (1L): add 186.1 g
Ethylenediaminetetraacetic acid disodium salt dihydrate
to 800ml of ddH20. Since this will solve difficult the use of
a magnetic stirrer is advised. Adjust the pH to 8.0 by adding
NaOH pellets, as soon as the pH of the solution nears 8.0, the
salts will slowly go into solution.
4. TE−4 (1L): add 10ml 1M Tris-HCl pH8.0 to 200µl EDTA
0.5M pH8.0, to make final concentrations of resp. 10 and
0.1mM, add ddH2O to 1L and sterilize.
5. Make an 80% ethanol Tris-based buffer by adding 20ml
sterilized 5.0mM Tris pH 7.5 to 80ml 100% ethanol. Please
note: <70% buffer will already wash out the bisulfite DNA,
resulting in dramatically lower yields.
Software
Several of the sections in this protocol use R (R Development
Core Team, 2011), a free-to-use open-source software for data
analysis. Several packages were designed in R with useful tools
to evaluate assay designs prior to the measurement on the
MassArray system, assess coverage and bisulfite conversion rate
and pre-process EpiTYPER R© data (RSeqMeth, 2008; MassArray,
2009). One of these, RSeqMeth, requires an older version of R.
We added the relevant functions of this package for download
on Github, so that they are usable with any R version above 2.13.
R scripts can be opened, read and edited using “script editors”:
Tinn-R or RStudio™ are both excellent choices since they are free
to download and use for non-commercial purposes, have good
manuals and a large user base.
1. Install a recent version of R using the CRAN website: http://
cran.r-project.org/.
2. Start the latest version of R as administrator (in Microsoft
Windows: right click on R in start menu or desktop icon and
select “run as administrator”) and run the following lines in R:
source (“http://bioconductor.org/biocLite.R”)
biocLite(“MassArray”)
install.packages(c(“reshape”,”ggplot2”,”gplots”, “devtools”))
Select a CRAN repository near to your location, install
packages. Of note: R may prompt you to update certain
packages. This is often not required for MassArray to work
properly, but is advisable to perform.
3. Next, download the files with our custom scripts from Github:
https://git.lumc.nl/molepi/EpiTyper.
Procedures
Amplicon Design
Whether EpiTYPER is suitable for a study depends on
the number of regions and samples you wish to measure.
One experimental run entails 384 reactions resulting in 126
measurements in triplicate with additional genomic DNA
(gDNA) and water control measurements. An EpiTYPER PCR
amplicon ranges from 100 to 600 bp, but is typically between 250
and 450 bp. For tips on how to select a region to measure, see
Note 1.
After selecting a region of interest, the reference sequence is
required as input for assay design software. The sequence of the
region of interest can be obtained from various databases. The
sequence should be annotated for deviations from the reference
sequence (e.g., Single Nucleotide Polymorphisms (SNPs)) that
may affect the measurement. If a specific strain of a (model)
organism is used, Sanger sequencing of the region of interest can
be used to identify deviations from the reference sequence. The
steps outlined below are based on the human genome.
1. Browse to the UCSC genome browser http://genome.ucsc.
edu/, go to “Genome” and select the most recent human
genome build (Kent et al., 2002).
2. Select the region of interest with 300 base pairs upstream and
downstream of the target region to allow some flexibility for
the assay design software.
3. To control for genetic variation and repeat sequences load
the latest common SNP (dbSNP ≥1% of samples, under
the “Variation” header) and RepeatMasker tracks (under the
“Repeats” header) and set them to “full” view.
4. Go to the “View” tab at the top right of the genome browser
and select “DNA”.
5. Press the extended options tab. Highlight the SNPs and
repeats. Make sure that each feature is easily and uniquely
identifiable.
6. Press “submit” and copy the DNA sequence into a text editor.
Go back to the extended options tab and select “reverse
complement” and press “submit” again. Copy this sequence
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into a text editor as well. Having both strands available
greatly enhances the design options.
7. Edit your DNA sequence: select your region of interest
with [] symbols and place <> around SNPs and repetitive
regions. For example:
AATGGAGTA<T>AGAAATAAGG[GCGAGCTACGCGA]
TTTGCTCATGG
The bases between <> will be excluded for primer design.
Primer overlap with common SNPs can lead to biased
PCR amplifications and artificial bi- and tri-modal DNA
methylation distributions. Also, repetitive regions should be
excluded in most circumstances. Excluding these regions
may increase the reliability of the PCR.
8. Browse to Epidesigner at http://www.epidesigner.com
or Methprimer at http://www.urogene.org/cgi-bin/
methprimer/methprimer.cgi. Both programs are user-
friendly options to design bisulfite primers to amplify a
region of interest. An advantage of Epidesigner, is that one
can immediately see which CpG sites can be measured
with EpiTYPER and design primers for both the forward
and reverse strand simultaneously. We here assume that
Epidesigner is used. If Methprimer is preferred, copy the
amplicon design parameters (annealing temperature etc.)
from Epidesigner.
9. Paste the edited sequence in Epidesigner.
10. Remove the check at the “Analyze CpGs in C reaction”. This
chemistry will not be used.
11. For “Select strand” choose “both”. This means that primers
will be designed for both the forward and reverse strand.
12. Amplicon length may be increased to 600 base pairs.
13. Press “begin”.
14. By hovering with the cursor over the designed amplicons
select two amplicons covering the region and/or CpGs of
interest for the forward strand (red) and two amplicons for
the reverse strand (blue). Please note that spheres in the
color red denote CpG dinucleotides that are not covered
in the final measurement. Sometimes masses of fragments
overlap or are too low or too high to measure on the
mass spectrometer. When the software has trouble designing
primers please see: Note 2.
15. Export the designs at the bottom of the page as “Order” and
as “Detailed”.
16. In the “Order” file rename the primers with suitable and
unique identifiers. The small letters in the primer sequence
denote tags added for the EpiTYPER biochemistry. They
are required for the transcription step, do not remove
them.
17. From the “Detailed” file take the genomic sequences for each
chosen amplicon and save them in separate tab delimited
files using a text editor like notepad. Preferably save the file
of each amplicon in a separate directory.
18. Start R (see Software Section of theMaterials and Equipment
Section).
19. Load in the EpiTYPER R scripts downloaded fromGithub in
R. Run in R:
source(“directory_of_EpiTYPER.r_supplemental_file/amplicon
Report.R”)
20. Perform an in silico amplicon prediction. The masses of
the fragments generated from the amplified sequence are
calculated so that one can assess if enough CpG dinucleotides
are covered by different measureable fragments. Run in R:
ampliconReport()
If your device has a wider mass range than between 1.5 and
7 kDa you can change the settings to allow a wider mass
range:
ampliconReport(minMass=1500, maxMass=7000)
Select a tab delimited text file with the genomic sequence
of the designed amplicon. The function will write several
output files in the directory of this tab delimited file.
Repeat this this step for each amplicon.
21. In each of the directories of the tab delimited text file with the
amplicon sequence, look for the Excel file named after this
tab delimited file with the extension: “T Report” and open
this file.
22. This file contains the sequences and masses of each so-called
“CpG unit”, that is a fragment containing one or multiple
CpG sites. The CpG sites are numbered from the 5′ end of the
genomic sequence. After each unit there might be a warning
message. If the fragment has another (non-) CpG containing
fragment within a few Dalton in the mass spectrum a
warning is given. These fragments often do not pass the
quality control because the closely neighboring fragment
causes the variation between triplicate measurements to
increase. Furthermore, one may see warnings denoting that
there is a “D_” or “OL_”with another CpG unit. This denotes
that the masses of either the unmethylated or the methylated
CpG unit overlaps with another CpG unit or non-CpG
containing fragment. DNA methylation levels from such
units cannot be used in downstream analysis.
Please make sure that enough CpG sites are covered by the
amplicon for a productive measurement. If the amplicon
does not satisfy your needs design a longer or shorter
amplicon or try an amplicon on the other DNA strand for
a better result.
23. Some amplicons may also contain a fragment with a TpG
and a cytosine. These fragments can be used to estimate
the bisulfite conversion for all samples in your study. To
automatically check for such fragments start R (see Materials
and Equipment) and load the MassArray package in R. Run
the following line in R:
library(MassArray)
24. Open the tab delimited file of the suitable amplicons and
copy the sequence. Denote the end and start of your forward
and reverse primer with > and < respectively. Run in R:
Name_of_amplicon <-“paste_the_amplicon_sequence_here”
Example:
Gene1<- “ATTCCTGGG>ATCGATCGGGAAAATTTCGC
GAAAA<GCCCTAATTAA”
25. Then run in R:
ampliconPrediction(Gene1)
A figure now appears showing multiple fragmentation
profiles of your amplicon. Look at the T(-) fragmentation
picture. CpG sites which can be measured are denoted
with numbers in blue. Those who cannot be measured are
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denoted in red. More importantly look for a green fragment.
These are fragments that can be used to assess the bisulfite
conversion, a key experimental parameter. If your device has
a wider mass range than between 1.5 and 7 kDa you can
change the settings to allow a wider mass range:
ampliconPrediction(Gene1, minMass = 1500, maxMass =
7000)
Primers designed for bisulfite PCRs have a higher failure
rate than normal primers. To save time, one may consider
ordering two primer pairs per region of interest. Make sure
that at least one region of interest has a fragment suitable
to assess the bisulfite conversion efficiency. Use the primer
sequences in the “Order” file(s), with the added EpiTYPER
specific tags to order your primers. Order HPLC purified
PCR primers for optimal results.
Sample Requirements
Pure and high molecular weight gDNA is important for efficient
bisulfite conversion and for good EpiTYPER R© measurements.
The OD260/280 should be between 1.7 and 2.0, lower and
higher values may indicate contamination or degradation and
the samples may be improved by additional cleaning steps.
On a 0.8% agarose gel the gDNA should be high on the gel
without a smear and the gDNA should show no additional
degradation after a DNAse test (i.e., 16 h incubation at 37 degrees
Celsius). The gDNA should also be devoid of RNA by including
an RNase step during the DNA extraction. Note that it is
important to quantify gDNA using a method that detects double-
stranded DNA like Qubit or Picogreen. A spectrophotometric
measurement (e.g., using Nanodrop) will generally overestimate
the DNA concentration if some degradation is present. For DNA
extracted from whole blood with samples this may often be
omitted as the resulting gDNA is generally of high quality.
In our hands, extraction of gDNA from other sources
than whole blood, especially liver and fat tissue, yielded
good results when the gDNA was isolated with the
phenol/chloroform method [including a washing step using
chloroform:phenol:isoamylalcohol (25:24:1, v/v) and a washing
step using phenol:isoamylalcohol (24:1, v/v)].
BS-PCR Assay Validation
To test and optimize the designed bisulfite PCRs (BS-PCR), treat
several gDNAs with bisulfite. Also use the same unconverted
gDNAs in the PCR tests as negative controls, to exclude
amplification of incompletely converted DNA. Perform the PCR
optimizations in the same machines and plastics as your final
EpiTYPER run.
1. Dilute the primers in a stock solution of 100 pmol/µl and
make a working solution at 1 pmol/µl separately for the
forward and reverse primers. We notice that with time many
BS-PCR primer pairs form dimers, resulting in lower PCR
efficiency.
2. Create bisulfite treated DNAs by the standard EZ DNA
methylation ZymoResearch protocol with a 12 h incubation
at 50◦C provided with the kit. One can bisulfite treat 10
DNAs per vial of bisulfite. After the protocol measure the
TABLE 1 | The PCR mix for one PCR reaction.
1*mix (µl)
MilliQ 0.42
10 × Hotstar Taq PCR buffer 0.50
dNTP mix, 25mM 0.04
Primermix forward (1 pmol/µl) 1.00
Primermix reverse (1 pmol/µl) 1.00
Hotstar Taq DNA polymerase (5 U/µl) 0.04
Bisulfite-treated DNA (5 ng/ul)/genomic DNA (5 ng/ul) or negative
control (MilliQ)
2.00
Total volume 5
concentration of the bisulfite DNA on Nanodrop and dilute
to 5 ng/µl. Note that the DNA is now single stranded.
3. Test 6 bisulfite DNAs, 4 genomic DNAs and 2 reactions with
water instead of DNA as negative controls with the standard
EpiTYPER PCR mix provided in Table 1.
4. Perform the BS-PCR. Incubate the PCR reactions (5µl) in
standard 384-well plates. Carry out the “step-down” PCR
thermal cycling protocol (Figure 2) with 15min at 95◦C,
followed by 4 cycles: 20 s at 95◦C, 30 s at 65◦C, and 1min at
72◦C, then followed by 4 cycles: 20 s at 95◦C, 30 s at 58◦C,
and 1min at 72◦C, and subsequently followed by 38 cycles:
20 s at 95◦C, 30 s at [AT]◦C* and 1min at 72◦C. Carry out the
final extension at 72◦C for 3min, and cool down the sample to
15◦C. This cycling protocol takes about 2 h. PCR product can
be kept at 4◦C. Avoid freeze-thaw cycles.
∗The annealing temperature [AT] is amplicon specific. The
[AT], optimal annealing temperature is determined by the
base pair composition of the primers. Therefore, annealing
temperature of the 38-cycle step may vary. Initially start at
53◦C for human and 48◦C for mouse and rat DNA sources
with testing.
5. Visualize 2µl of PCR product on a 1.5% agarose gel along with
an appropriate DNA ladder.
6. A successful PCR amplicon should show a clearly visible band
at the correct height without any by-products for all tested
bisulfite treated DNAs. Also, there should be no amplification
of the gDNA and water controls. Furthermore, check for
excessive primer-dimer formation in the water control PCR
reactions. If the primer dimer formation is of similar intensity
as the BS-PCR product primer dimer formationmight become
a problem in the final EpiTYPER experiment.
7. For tips on how to optimize your bisulfite PCRs see Note 3.
Bisulfite Treatment of Samples (1 h in the
Afternoon, Overnight, and One Morning)
In any quantitative measurement, the occurrence of batch effects
is inevitable. Therefore, randomization of samples across bisulfite
reactions is recommended. For bisulfite treatment of larger
numbers of samples, use of a 96-well based kit will help to reduce
batch effects. We recommend the EZ-96 DNA methylation kit
by Zymo Research, which entails 12 h incubation at 50◦C for
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FIGURE 2 | Step-down bisulfite PCR.
the bisulfite reaction. To reduce salts in the final bisulfite treated
DNA we made changes to the last wash step and the elution
step of this protocol (see below). An alternative protocol with
temperature cycles is also provided by Zymo Research, which
should result in a higher bisulfite conversion. It is recommended
by Illumina for the Illumina 450K DNA methylation arrays, but
this protocol will result in additional degradation of the DNA
sample, which may result in a lower success rate when measuring
longer regions.
For situations with slightly degraded DNA or very little
amounts of genomic DNA as starting material one might
consider alternatives like the Qiagen Epitect kit. This kit can
both handle small amounts of gDNA and also has a protocol for
formaldehyde treated samples. We have successfully used this kit
to bisulfite treat slightly degraded gDNA.
EZ-96 DNA Methylation Protocol
1. Calculate the amount of gDNA solution which is necessary
for 1µg of gDNA. The maximum volume of gDNA solution
that can be used in the bisulfite reaction is 45µl. Down to
100 ng and up to 2µg of DNA can be used with this type of
column. Themanufacturer recommends 500 ng–1.5µg gDNA
for optimal conversion.
2. Follow the EZ-96 DNA methylation protocol, but take extra
care of the following points and alterations to the standard
protocol.
• Never put the bisulfite conversion reaction on the gDNAs
on ice.
• Try to minimize the light exposure until the completion of
the M-Desulphonation step.
• Preferentially prepare the CT conversion reagent directly
before the intended use. Dissolved CT conversion reagent
can only be stored at −20◦C for a maximum of a week
and only if it is frozen quickly after it is prepared. Be aware
that the older the dissolved CT conversion reagent becomes
the chance that the bisulfite reaction will be incomplete
increases. Keep dissolved CT conversion reagent away from
light.
• Replace the second wash step after the M-Desulphonation
buffer incubation with the Tris-based wash buffer (see
Materials and Equipment). This alteration to the protocol
is important to minimize the amount of sodium in the
converted BS-DNA solution. Sodium will stick to the
fragments and shift the mass of your fragments by 22
Dalton, which is very close to the 16 Dalton shift of
methylated fragments.
• Replace the last step of the bisulfite protocol, the EZ-96
DNA methylation Elution step. Incubate the column with
30µl TE−4 for a minimum of 1min. Centrifuge for 5min
at 2500 × g to elute bisulfite converted DNA. Repeat this
step for a 2nd time to obtain 60µl of eluted BS-DNA.When
converting less than 500 ng of gDNA do the first elution
with 20µl and the second with 15µl.
• Measure the concentration of your bisulfite converted
DNA (BS-DNA) by UV spectrometry. The 260/280 will be
between 1.9 and 2.15 on average. The normal concentration
range is: 15–25 ng/µl. Values deviating from these normal
ranges are generally caused by low quality gDNA, while
much higher yields may be caused by extensive degradation
of your sample or ethanol being presents in your BS-DNA.
Test samples with deviant values (see Quality control of
bisulfite treated samples) or redo the bisulfite conversion.
Please note that this concentration is an overestimation of
the true concentration because of the degradation during
bisulfite treatment.
• Measure the volume of eluted and concentrated DNA for a
subset of samples and calculate the amount of TE−4 that is
needed to dilute the samples to roughly 5 ng/µl.
Store the BS-DNA at 4◦C as repeated freezing and thawing of BS-
DNA results in a lower BS-PCR efficiency. Do not store BS-DNA
for a prolonged period.
Quality Control of Bisulfite Treated Samples (Half
a Day)
To determine whether the bisulfite treatment was successful
and to evaluate how fragmented your bisulfite-treated DNA
(BS-DNA) has become, one can perform several test BS-PCR
reactions with primers resulting in amplicons of increasing
lengths (Table 2). These PCRs are highly specific for BS-DNA
and should yield clear, single PCR products on a 1.5% agarose
gel (Ehrich et al., 2007). Please be aware that these reactions are
for human DNA only. Successful amplification indicates that the
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TABLE 2 | The primers used for assessing the degradation of your bisulfite treated DNA.
Assay name* Left primer sequence** Right primer sequence*** Target length
SQNM_QC_163 TGAGGTGAATTTTAGGGATTGTAGG ACCTCACAAACTCTCCCAAACC 163
SQNM_QC_176 GTTGAGGGGTAGAGGGAAGTGT ATCTTCAAACAAAAAAATAACC 176
SQNM_QC_255 TTTTTATTAAAGGTTAAGGTGGTGAT CAAAACAAAATCCCCACAACC 255
SQNM_QC_328 GGTTTGGGAGAGTTTGTGAGGT TAACACAAAAAACCCCTTCCTACCA 328
SQNM_QC_362 GTTGAGGGGTAGAGGGAAGTGT CTCACCAAAAACCAAAATAATAACC 362
SQNM_QC_477 TGTATATGGTTGGGGGTTAGTTG CCCTCACCAAAAACCAAAATAATAAC 477
SQNM_QC_593 GGTGAATTTTAGGGATTGTAGGGTTTTA AAACTTCTCCCTCCCAAACCACTAT 593
SQNM_QC_678 AGGGTTTGTTGGGTGATTGGAT AAACTTCTCCCTCCCAAACCACTAT 678
SQNM_QC_795 GTTTTTTTTAATTGGGGTGGTTT CTCACCAAAAACCAAAATAATAACC 795
SQNM_QC_960 TTGTTAGATTTTAGATGTTTAAGGTGTTTT CCTCACCAAAAACCAAAATAATAACC 960
*Primers as originally published by Ehrich et al. (2007).
**Primer 10 bp tag prior to left primer sequence: 5′—AGGAAGAGAG [primer sequence]-3′.
***Primer 31 bp tag prior to right primer sequence: 5′—CAGTAATACGACTCACTATAGGGAGAAGGCT [primer sequence]—3′.
BS-DNA is good for subsequent BS-PCR of your amplicons of
interest.
1. Choose 3 to 4 quality control BS-PCR primer pairs (Table 2).
Choose one primer pair in the lower size ranges (150–250 base
pairs) and one primer pair resulting in a PCR amplicon of
similar size as your project primer pairs. Select at least one
primer pair resulting in an amplicon of a slightly larger size
than your project primers.
2. Perform BS-PCR for at least 6 of the samples on a 96-
wells bisulfite plate with the test primers using the PCR mix
and cycling conditions described above and Table 1. Use an
annealing temperature of 53◦C for the last step. Include gDNA
and water as negative controls.
3. To confirm successful bisulfite treatment and PCR, run 2µl
of the PCR product on a 1.5% agarose gel together with an
100 bp DNA ladder to confirm successful PCR amplification
and amplification specificity on the bisulfite treated DNA. No
visible PCR product should be visible for the gDNA and water
controls.
4. There should be clearly visible BS-PCR products for each
size range. This denotes that your BS-DNA is suitable for
EpiTYPER measurements.
5. For what to do when (some) samples show no QC BS-PCR
products, or only products at the lower size ranges, please refer
to Note 4.
Designing Your Plates (1 h)
Perform all EpiTYPER steps on a bisulfite treated sample in
triplicate on a 384 PCR plate. Since measurement are done in
triplicate, one can measure up to 126 samples taking into account
that some wells are used to add water and unconverted gDNA as
PCR controls.
• As mentioned in the section on bisulfite conversion, samples
should be randomized. If your project is larger than one 384
plate randomize samples across the 384 plates, preferably with
similar proportions of samples from the different bisulfite
plates on each 384 plate as to minimize technical batch effects.
• When uploading the sample list to the plate editor software the
software will automatically sort the sample list. We advise the
following naming convention of your sample list: a number
from 001 to 384 denoting the well on the 384 PCR plate,
followed by a number unique for each sample (note that
the software does not handle text), followed by a number
denoting if it is the first, second or third measurement for
that sample. These numbers are separated by an underscore.
Examples: 001_5186_01; 212_5186_02; 310_5186_03. Well
001–012 should denote the first column on the 384
plate.
Use of this format allows a quick automated creation of the plate
in the EpiTYPER software and allows the use of an R script we
wrote to automatically perform the data pre-processing (Note 6).
Performing the EpiTYPER® Measurements
The exact EpiTYPER protocol and the required time from start
to finish are heavily dependent on the available MassArray setup
and may vary. Therefore, this section is restricted to several
points and tips that should improve the overall measurement
process, independent of the exact set-up. In short, the protocol
starts with the bisulfite PCRs on your bisulfite converted samples
in triplicate for each PCR amplicon.
• One may consider to first do all steps for one 384 plate, if a
large experiment is performed.
• After filling out the gDNA and PCR mix always check for air
bubbles. If you find air bubbles gently tap the plate to get rid of
them or centrifuge the plate.
After the BS-PCR shrimp alkaline phosphatase is added to nullify
the unincorporated DNA nucleotides.
• Directly after this treatment there is opportunity to put 2µl
of roughly 8 samples, the water control and the unconverted
gDNA on a 1.5% agarose gel with an appropriate DNA ladder
per plate. Place the 384 plate at 4◦C temporarily. If one clear
PCR product is observed, one can proceed with the rest of the
EpiTYPER protocol.
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After shrimp alkaline phosphatase treatment the samples are
pipetted to a new and clean 384 plate on which the T7 reverse
transcription and base specific cleavage is performed.
• Use the remaining BS-PCR product to Sanger sequence
a subset of your samples to confirm bisulfite conversion
efficiency. For projects with a small number of samples and
large number of PCR-reactions it is recommended to Sanger
sequence all your samples for at least one amplicon.
• Freeze the left over plate at –20◦C for possible additional
quality control checks later on.
After T7 reverse transcription and base specific cleavage water
will be added. Next, a cleaning resin is added that eliminates salts
whichmay interfere with the mass spectrometer measurement.
• Add sterilized milliQ water to your plate.
• After adding and mixing the resin it is possible to freeze the
plate for measurements later on the mass spectrometer. When
one wants to (re)measure a frozen plate redo the mixing and
spin down of the resin after thawing. But be careful, repeated
thaw and freeze cycles will lead to reduced signals.
Now the samples can be transferred to the 384 SpectroCHIP II
which is used in the mass spectrometer.
• Test the spot size on a previously used SpectroCHIP II and
also assess the spot size on the first SpectroCHIP II used for
the new project. Loading too much or too little sample on the
SpectroCHIP II will result in noisy measurements and does
vary dependent on the ambient temperature and air pressure.
The optimum value is dependent on the available set-up and
should be provided by the manufacturer’s contact person.
• Measure one SpectroCHIP II first and proceed with Data pre-
processing and clean up and Note 5, dealing with assessing
the quality of the measurement in terms of measurement noise
and signal quality, and assess the quality of the measurement
before proceeding with the measurement of the entire
project.
Data Pre-processing and Clean Up
After the measurement on the mass spectrometer the data needs
to be pre-processed.
1. Open your measurement in the EpiTYPER R© Analyser
software and select one PCR amplicon.
2. Manually inspect the spectra of multiple samples for
irregularities by eye. For details on what to look for see
Note 5. Please note that manual inspection of the spectra
for measurement noise and peaks not expected based on the
amplicon sequence is essential for reliable and high quality
EpiTYPER data.
3. Go to “File”, “export grid” and check the boxes at “rotate
table data” and “Include comments”. Save the file as “Tab
separated values (∗.txt)” with a unique name and in a
unique directory folder. This is the file to perform data
pre-processing and quality control on.
4. Exported data for plates with multiple primers will have
many NAs for the wells on which another PCR was
performed. Furthermore, the triplicate measurements will
not be sorted together. An R script is provided to handle the
data pre-processing. If you want to use this tool see Note 6.
If not, you can do the data cleaning and pre-processing by
taking the following steps.
• Set CpG units of samples with less than two successful
measurements for this CpG unit as missing.
• Set CpG unit measurements with a standard deviation of
0.1 (10% methylation) and larger for a sample as missing.
• After these two criteria calculate the mean methylation
ratio per CpG unit per sample.
• Remove CpG units with a success rate lower than 80%
across samples.
• Remove CpG units as a whole when the CpG unit has as
a warning remark “D” or “OL”. These warnings denote
overlaps in mass between other fragments which makes
that the DNA methylation signal cannot be assigned
uniquely to one CpG unit. Data for such CpG units may
be unreliable and is not quantitative.
• Remove CpG units for which a common SNP is present
in the fragment. See the genomic sequence exported from
the genome browser (section on Amplicon design).
• Check the distribution of the DNA methylation data per
CpG unit (e.g., by making a histogram). A bi-modal or
tri-modal distribution indicates that the measurement
of this CpG unit is confounded by a (unknown)
SNP in the fragment of the CpG unit. Exclude such
a CpG.
5. When performing a project with a limited number of
samples Sanger Sequencing of these samples might have
indicated that some samples have an incomplete bisulfite
conversion, remove such samples. For a larger project
Sanger Sequencing of all samples is often not feasible. In
such a case perform a qualitative check of the bisulfite
conversion of your samples and remove samples for which
this qualitative measure indicates an incomplete bisulfite
conversion (Note 9).
Analyzing DNA Methylation Data
The optimal way to analyze the DNAmethylation depends on the
project, sample size, and distribution of your DNA methylation
data and covariates of interest. Bisulfite conversion plate and
also the EpiTYPER experimental plate may be included as
covariates in the statistical analysis of larger projects, as they
may have an influence on DNA methylation values. For single
CpG sites linear regression often suffices. When one wishes to
analyze a region as a whole two approaches are often seen in
literature. First, the average of the CpG sites can be calculated per
sample. This approach causes some information to be lost, but is
straightforward in its analysis and interpretation. Linear mixed
models (LMMs) may be employed (Loke et al., 2013). These
take into account all information on all single CpG units. DNA
methylation of adjacent CpG dinucleotides may be correlated
and there is also a stronger correlation within a sample. Such
correlation structures need to be taken into account to make
inferences on statistical significance of regions and LMMs may
handle such correlation structures.
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FIGURE 3 | UCSC view of the LEP upstream promoter region spanning 290 bases. Here a small part of the distal LEP promoter region is shown. The view
shows that there are no frequent SNPs nor any repeats in this region. ENCODE data indicates that CTCF may be binding here.
Typical Result
Here, we will discuss the design andmeasurement of an upstream
region of the human Leptin (LEP) promoter. Previously we
found that DNA methylation of the LEP proximal promoter
is associated with various developmental insults (Tobi et al.,
2009, 2011; Obermann-Borst et al., 2013). As it is possible that
DNA methylation differences effects extend into neighboring
regulatory regions (Tobi et al., 2012), it is of interest to explore
the larger LEP promoter region.
Design
First, we used the UCSC genome browser to gain the sequence
of the LEP promoter, acquiring the first 5 kb upstream of
the transcription start site and annotated frequent SNPs and
repetitive elements. Using Epidesigner we designed multiple
amplicons for the region including one spanning for 290 bases
along chr7 and overlapping a CTCF binding site according to
ENCODE CHIP-seq data (Figure 3). As CTCF binding may
be methylation dependent, we took this amplicon further for
characterization. This sequence contained no frequent SNPs that
could interfere with the reliability of the measurements as shown
in Table 3. The amplicon contains 5 CpG sites, of which one
cannot be measured because the mass of the CpG unit is too
low (Figure 4). The ampliconPredict function (RSeqMeth, 2008)
indicates that none of the CpG units overlap in mass, have an
identical mass, nor are any fragments located within 16Da of
other fragments (Table 4).
BS-PCR Validation of LEP
Next, we tested the PCR of this amplicon using 8 test gDNA
samples that were extracted from whole blood and bisulfite
converted as described earlier. We included additional controls,
namely non-converted genomic DNA and several PCR reactions
with water added instead of gDNA. One clear band was observed
TABLE 3 | Upstream sequence of LEP.
chr7:127875489-127875778
GAGGTGCTTATGCAAGCAGTCTGGCAAAACACCTCTTTAGGGACAAACGTAGA
GCTGGAG
ACTTGGGACGCCTCAGGATGTGTCAGATCACAGCTTTCTGCAGGGCACAAGGC
TTCTTGC
TGCTTCTCCAGAACATCTCTCCAAATGCCTGTGCAGCCCTGGGTACCTGGGCA
GGGTCCA
GCTCTACAAAGGATCATGGCTCGAGTCCTTCCGCTCCAATGGGAAAGACCAAC
CAAGTGA
GAGAAAGAGCATGCCGCCCAGAGGGGGAGCTGGTTGCCATTGTCCTCTTG
on a 1.5% agarose gel (data not shown), but the intensity of the
band was not that strong. Therefore, the PCR was redone with
a 3◦C lower annealing temperature (50◦C) in the last step of
the step down protocol PCR protocol. This yielded a strong and
still unique PCR product on gel (data not shown) and we chose
to measure this amplicon on a small number of samples using
EpiTYPER.
Measurement of LEP with EpiTYPER
Ten samples, one non-bisulfite converted gDNA and one PCR
with water added instead of gDNA were measured in triplicate
on a 384 plate.
First, we inspected at the entire mass spectrum of several of
these 12 triplicate measurements. The measurements all showed
a nice baseline following the x-axis (Figure 5A), indicative
of little measurement noise, and the signals of the predicted
peaks are high. Moreover, additional peaks were distributed
randomly across the measurements and lower in intensity than
the predicted peaks. Together, this is indicative for optimal
spotting and laser intensity settings, little unspecific cleavage
and no non-specific PCR product formation (see Note 5).
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FIGURE 4 | Fragmentation of LEP promoter amplicon. The fragmentation of the LEP amplicon is given in gray lines. Red dots denote the measureable CpG unit.
Clear from the figure is that four out of five CpG unit are measureable and that each CpG dinucleotide is contained in a separate fragment.
TABLE 4 | ampliconPredict result for the 290bp LEP amplicon.
Name Base mass Desc <15.9Da
CpG_Unit_2 2260.426 CpG_2 NA
CpG_Unit_3 2509.587 CpG_3 NA
CpG_Unit_4 4524.87 CpG_4 NA
CpG_Unit_5 2878.821 CpG_5 NA
This is the prediction given by the EpiTYPER.r script taken from the RSeqMeth package.
Four out of 5 CpGs are measured in separate fragments. The mass of the fragments range
from 2260Da till 4525Da and no other fragments are located with 15.9Da, indicating
that the measurement will not be influenced by the signal for another fragment. Also no
warnings are given of possible overlaps between CpG units. Also no CpG unit has the
same mass as another.
When looking at some CpG units in more detail the spectra
were smooth (Figure 5B), again indicative of a good quality
measurement.
Next, we exported the raw data from the EpiTYPER software
and found that the EpiTYPER software has given a warning for
the CpG site that cannot be measured (Table 5); its mass is too
low to bemeasured. For CpG unit 3 an additional remark is given,
namely “SN3”, indicating that a non-CpG fragment overlaps the
unmethylated CpG unit 3 fragment. The EpiTYPER software is
often successful in subtracting the signal of such fragments from
the methylation measurement. Nonetheless, such units often
have a higher measurement error. Also in this case the standard
deviation of the triplicate measurement is high and only 3 out of
10 samples have an observation that passes the QC filtering steps
(Table 5). All other 3 CpG units however, have a high quality
measurement and can be used for analysis purposes.
Notes
Note 1. Advice on Where to Measure
In many instances one starts with a gene or set of genes. The
genomic regions in such instances are too large to assess in their
totality and it is currently largely unknown which CpG sites
have a regulatory potential. For some genes a thorough literature
search may yield some insights. However, for most genes little is
known.
FIGURE 5 | Example of mass spectra resulting from the measurement
with EpiTYPER. (A) Shows an entire mass spectrum of a single
measurement of a sample. Black peaks are measured fragments while the
blue and red dotted lines denote a selected CpG fragment in the EpiTYPER
software. This particular part of the mass spectrum is shown in (B). The
spectrum is nice and smooth, indicating a good quality of the measurement.
ENCODE and Roadmap Epigenetics data can be used to select
regions of interest. The popular UCSC and ENSEMBL genome
browser are not always up to date with the latest ENCODE and
Roadmap data. ENCODE has an excellent UCSC portal by which
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TABLE 5 | Results for the LEP amplicon measurement.
Standard deviation CpG_1 CpG_2 CpG_3 CpG_4
Warning L_mass NA SN3 NA
Sample
1 NA 0.025 0.103 0.010
2 NA 0.012 0.076 0.000
3 NA 0.012 0.119 0.010
4 NA 0.015 0.248 0.006
5 NA 0.010 0.025 0.006
6 NA 0.067 0.319 0.055
7 NA 0.021 0.154 0.006
8 NA 0.035 0.112 0.006
9 NA 0.015 0.020 0.006
10 NA 0.026 0.140 0.012
gDNA NA NA NA NA
water NA NA NA NA
Filtered Methylation values CpG_1 CpG_2 CpG_3 CpG_4
Sample
1 NA 0.713 NA 0.930
2 NA 0.813 0.487 0.930
3 NA 0.783 NA 0.930
4 NA 0.817 NA 0.937
5 NA 0.790 0.897 0.923
6 NA 0.757 NA 0.903
7 NA 0.797 NA 0.927
8 NA 0.807 NA 0.937
9 NA 0.787 0.880 0.933
10 NA 0.830 NA 0.937
gDNA NA NA NA NA
The standard deviation and filtered final methylation values (ratio) is given. CpG unit 1 has
a low mass and cannot be measured (data is all missing: NA) while CpG unit 3 has a
warning message (“SN3”) denoting a non-CpG containing fragment overlapping the unit.
This results in an overall higher technical variability between the triplicates, resulting that
only 3 out of 10 samples have a measurement passing the QC steps.
many epigenetic datasets can be visualized. The Roadmap project
also has a dedicated browser. All links can be found at: http://
www.roadmapepigenomics.org/. ENCODE has an “experiment
matrix”, while the roadmap has a similar “epigenome atlas”
containing overviews of the available data types and datasets. The
data is continually evolving as both projects continue. Therefore,
we limit ourselves to some general tips on which type of data
might be a good starting point in your effort to prioritize regions
for EpiTYPER measurements.
• One may start by visualizing tracks containing DNA
methylation data in tissues and cell lines relevant for the
planned study. Regions exhibiting variation between tissues
and cell types may be prioritized.
• Both projects provide so-called chromatin states for multiple
cell lines and tissues, which can be used to find active
(alternative) promoters and enhancers in cell types of
interest. In the regular UCSC genome browser the chromatin
states for the 8 main ENCODE cell lines can be found
under “Regulation” and the “ENCODE Histone Modification
Tracks” tab. Chromatin states for more and more cell types are
becoming available.
• Transcription factor CHIP-seq data is also a good start. Are
there any transcription factors that are DNA methylation
sensitive and overlapping with interesting HMM chromatin
promoter and enhancer states in and around your gene of
interest? Examples of DNAmethylation sensitive transcription
factors include NFkβ, CTCF, MBD2, andNGF1-A. Predicted
binding sites might likewise be useful to prioritize regions to
measure.
• Another indication of functionality can be inferred by
extracting DNA methylation levels for multiple cell types in
certain regions and correlate the DNA methylation levels with
normalized RNA seq data of neighboring genes in the same
cell types. Note that data may not be generated using the same
cell culture experiment or donor.
Note 2. Problems with Designing a Bisulfite PCR
Amplicon
Sometimes it is difficult to design primers for some regions. The
following changes from the standard protocol may be useful.
• Set the minimum primer size to 16 basepairs and try to design
primers.
• Secondly set the maximum amplicon size to 650 basepairs.
Several groups have worked with amplicons larger than 500
base pairs. However, good quality input gDNA is required.
• Remove the check at “maximize coverage” and lower the
“Product CPGs” option.
• As a last resort, set the number of primer “Non-CpG ‘C’s” to 3.
However, test the specificity for bisulfite converted DNAmore
rigorously for these amplicons, by testingmore genomicDNAs
(see BS-PCR assay validation).
Note 3. Optimizing Your Bisulfite PCRs
The bisulfite PCR is an important parameter in the EpiTYPER R©
protocol. A low amount of product will result in an unfavorable
signal-to-noise ratio.
• If the BS-PCR gives a weak product and/or some weak by-
products, try a higher temperature in the first two steps,
followed by a lowered annealing temperature in the final
cycling step. Start by increasing your first two annealing
temperatures by 2 degrees and decreasing your final annealing
temperature by 3 degrees.
• The amount of a weak unique product can be increased by
using more primer and more taq polymerase (up to 50%).
Adding more BS- DNA only helps when the BS-DNA was
rather degraded. Extra PCR cycles will not be very effective in
increase the amount of product, since the number of cycles is
already high.
• Multiple strong PCR products, re-design primers.
• No product at all, try to use much lower annealing
temperatures or re-design primers.
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Note 4. Negative Outcomes of Bisulfite Quality
Control
If no or little product is found in the test BS-PCR reactions,
it is likely that the BS-DNA is not suitable. The most likely
cause is that your input-DNA was already slightly degraded or
dirty. Another common cause is that an error was made during
the bisulfite protocol. Some additional considerations are now
necessary.
• When all size ranges failed, re-assess the sample purity of
the samples for which these test BS-PCRs failed. We found
that it may help to perform another protein K treatment
and traditional chloroform DNA clean-up before re-doing the
bisulfite treatment.
• Most often only test BS-PCR reaction of the larger size ranges
fail. This often indicates extended degradation of your samples
during bisulfite treatment. If the amplicons in your project are
smaller than the failed QC BS-PCR, your measurements may
still be successful. However, since failed QC BS-PCRs may also
point to a failed bisulfite conversion it is advisable to proceed
with caution and first perform Sanger sequencing of the
bisulfite converted DNA to confirm complete conversion for a
subset of the samples (on the 96-wells plate) before proceeding
with the EpiTYPER measurements. If your amplicons of
interest are of a similar size range as the failed test BS-PCRs it
will be necessary to re-do the bisulfite treatment. A bisulfite kit
able to handle slightly degraded DNA, like the Qiagen Epitect
kit with FFPE protocol might be considered as an alternative
in such cases.
Note 5. Inspecting EpiTYPER® Mass Spectra
It is important to manually inspect a proportion of the generated
EpiTYPER spectra in the Analysis software to identify possible
issues with your biochemistry, mass spectrometer, or automated
liquid handlers.
• Open the EpiTYPER R© software and check that the “T reverse”
tab is activated.
• Set the “Spectrum View” tab on “recalibrated.”
• Look at multiple samples. Does the baseline of the spectrum
run parallel with the x-axis? The vast majority of samples
should have a low baseline. If lots of samples have arched
shaped baselines there might be something wrong with
the laser intensity or the spotter. Arched shaped spectra
will negatively influence the quality of the measurement by
inflating the background signal, especially in the lower mass
ranges.
• In the “View” panel go to “Enable/Disable Pane”, check
“additional Peaks”. In the panel below an additional tab now
appears. Look at multiple samples. Go through the additional
peaks and confirm that they are mostly not larger than the
background signal. Normally roughly 10–30 additional peaks
are called by the software. If high signal intensity additional
peaks are found in many samples there might be an unspecific
BS-PCR product in your reaction. Double check the PCR
amplicon sequence file to make sure the correct sequence
was used. Also, place some BS-PCR reactions on gel to
validate to no non-specific PCR products are confounding the
measurements.
• Go to a sample and zoom in to a level that roughly 4–
8 individual peaks can be discerned. Are the peaks and
background baseline nice and smooth? If a significant
proportion of your samples show a very jagged baseline
and peaks that do not have a smooth curve there might be
something suboptimal in the mass spectrometer settings or the
SpectroCHIP II. Consult with the manufacturer to verify the
mass spectrometer settings are still optimal.
• Zoom in to the lower mass ranges (1000–2000Da) and higher
mass ranges >7000Da. Normally some variation is seen in
outer mass ranges, indicating a slightly less optimal signal-to-
noise ratio. Especially in the higher mass ranges the optimal
detection cut-off may vary depending on the conditions
during the spotting of the sample on the mass spectrometry
plates. When the baseline becomes jagged and many
additional peaks are called by the EpiTYPER software changes
in the spotting conditions and/or mass spectrometer are
needed.
• Look at samples with some missing values. Zoom in to the
missing CpG units in the spectrum. Are they indeed missing
peaks, or are the peaks low compared to the background?
Lots of missing peaks might indicate that not enough BS-
PCR product was formed or that the transcription step went
suboptimal. It is good to try to discern if there is a pattern to
such samples: are the samples located next to each other on a
384 plate? In such case there might be a bad pipetting channel
in one of your automated liquid handlers. If not, one might
need to place some BS-PCRs on agarose gel and assess if it
might be prudent to re-do the measurement.
Note 6. Running the R Data Cleaning and
Pre-processing Script.
To aid data pre-processing, we provide an R script that handles
the data pre-processing and data cleaning.
• Scripts are available in GitHub using the following link:
https://git.lumc.nl/molepi/QC_Epityper.
• Set your R working directory to the location of your exported
DNA methylation data, have one unique directory with all
DNAmethylation data from all plates belonging to a particular
project. Run the following line in R:
setwd(“C:/directory_with_DNA_methylation_data”)
• Load the scripts downloaded from Github to R by referring to
the file as follows, run in R:
source(“C:/location_of_Supplemental_file/EpiTYPER.r”)
• Define samples you wish to exclude from analysis. For
instance, the genomic DNA and negative controls. Run the
following line in R, denoting any samples you wish to exclude
with brackets:
Donots <- c(“negative_control”, “gDNA1”, “gDNA2”)
• Define the directory where the script can find all relevant
EpiTYPER data for one project. Run the following line:
directory <- getwd()
• Do the pre-processing and QC. If you want to remove
CpG units with masses overlapping with other fragments
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set “remove=T”, otherwise: “remove=F” If you want to
set another cut-off for the CpG units please change
“succesrate=0.8” (successrate > 80%) to the required
threshold. Remove samples by adding the variable with the
samples to exclude to the “sampRemove” argument, if no
samples need to be removed set “sampRemove=NULL”. Run
in R, with the possible desired edits:
QC.Epityper(directory, succesrate=0.8, remove=TRUE,
sampRemove=donots)
• An “output” directory is automaticallymade in the directory of
your DNAmethylation data. A tab delimited text file is created
for further analyses for each amplicon. The script will also have
created PDF files with success rates and other metrics per PCR
amplicon in the same directory.
Note 7. Qualitative Assessment of Bisulfite
Conversion
For a large project it is not feasible to do an assessment of the
bisulfite conversion rate for all samples with Sanger Sequencing.
After having confirmed the bisulfite conversion for a subset
of your samples by Sanger Sequencing it is possible to get
a qualitative assessment for each sample if you have a PCR
amplicon with a so-called conversion control fragment. An
additional data export from the EpiTYPER software is required
to perform bisulfite conversion assessment using the MassArray
package. For additional info and more details please refer to
the Bioconductor MassArray page (on http://www.bioconductor.
org/ search for “MassArray”).
• Make sure to have the genomic sequence of your amplicon
with conversion control available. Verify that no common SNP
is present in this conversion fragment. Use the latest common,
≥1% of samples, dbSNP version to this end.
• Open the EpiTYPER R© Analysis software.
• Load one amplicon of your plate of interest. This script can
only be performed per amplicon and per individual 384 plate.
• Once you have opened an individual amplicon in the
EpiTYPER R© application, enable display of both the “T
reverse” and “C reverse” tabs.
• Then go to “View”, “Enable/Disable Pane”, make sure that both
the “Show All Matched Peaks” and “Show All Missing Peaks”
options are checked.
• Go to “File”, “Export Grid” and save the tab delimited file in a
unique directory with a unique name.
• Open R and run the script:
library(MassArray)
• Annotate your amplicon sequence with the start and end of
your forward and reverse primers using > and < respectively.
Example:
Gene1 <- “ATTCCCAAAT>AATTTACGCGAATGGGGCC
GCG<TAACCAACCTTTGG”
Enter your amplicon in R and run the script:
amplicon <- “paste_sequence_of_your_amplicon_here”
• Set the work directory of R to the work directory of your
exported tab delimited file by running the following lines in R:
directory_name=“C:/Directory_name_of_exported_file”
setwd(directory_name)
• Then processes your data, and run:
data <- new(“MassArrayData”, amplicon, “Name_of_
Exported_file.txt”)
Depending on your computer this may take a considerable
amount of time.
• Now determine your bisulfite conversion. Run:
bisulfite <- lapply(data, slot, “quality.conversion”)
conversion <- 100*as.numeric(lapply(bisulfite, mean,
na.rm=TRUE))
• The resulting vector of numbers is the average bisulfite
conversion per well in the 384 plate. The value denoted
should be <2 per measurement. Higher values may denote
a sample with an incomplete bisulfite conversion or some
amplification of unconverted DNA. For some samples no
assessment (NA) can be made. In most cases a high
background signal around the conversion control fragment
is the cause. The order of samples is the same as the order
in the EpiTYPER R© Analysis software. Please note that this
assessment of bisulfite conversion is a qualitative measure, not
an exact measure, of the bisulfite conversion. The software
is looking for a fragment that is inherently low in signal
intensity. The signal-to-noise ratio is therefore always very
unfavorable.
• The vector can be saved as tab delimited text file by running:
write.table(conversion, file=“desired_name_of_file.txt”,
col.names=F, row.names=F, sep=“\t,” quote=F)
Acknowledgments
We wish to acknowledge our support from the U.S.A.’s
National Institute of Aging [R01AG042190], The European
Union’s Seventh Framework Program IDEAL [259679] and The
Netherlands Consortium for Healthy Ageing [#05060810]. The
funders had no role in decision to publish or preparation of the
manuscript.
References
Christensen, B. C., Kelsey, K. T., Zheng, S., Houseman, E. A.,
Marsit, C. J., Wrensch, M. R., et al. (2010). Breast cancer DNA
methylation profiles are associated with tumor size and alcohol and
folate intake. PLoS Genet. 6:e1001043. doi: 10.1371/journal.pgen.
1001043
do Amaral, C. L., Milagro, F. I., Curi, R., and Martínez, J. A. (2014).
DNA methylation pattern in overweight women under an energy-restricted
diet supplemented with fish oil. Biomed Res. Int. 2014:675021. doi:
10.1155/2014/675021
Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos,
G., et al. (2005). Quantitative high-throughput analysis of DNA methylation
patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci.
U.S.A. 102, 15785–15790. doi: 10.1073/pnas.0507816102
Ehrich, M., Zoll, S., Sur, S., and van den Boom, D. (2007). A new method for
accurate assessment of DNA quality after bisulfite treatment. Nucleic Acids Res.
35:e29. doi: 10.1093/nar/gkl1134
Frontiers in Genetics | www.frontiersin.org 13 September 2015 | Volume 6 | Article 287
Suchiman et al. Quantitative DNA methylation EpiTYPER® measurements
Figueroa, M. E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X.,
Christos, P. J., et al. (2010). DNA methylation signatures identify biologically
distinct subtypes in acute myeloid leukemia. Cancer Cell 17, 13–27. doi:
10.1016/j.ccr.2009.11.020
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M.,
et al. (2002). The human genome browser at UCSC. Genome Res. 12, 996–1006.
doi: 10.1101/gr.229102
Loke, Y. J., Galati, J. C., Morley, R., Joo, E. J., Novakovic, B., Li, X., et al.
(2013). Association of maternal and nutrient supply line factors with DNA
methylation at the imprinted IGF2/H19 locus in multiple tissues of newborn
twins. Epigenetics 8, 1069–1079. doi: 10.4161/epi.25908
MassArray: Analytical Tools for MassArray Data [computer program]. (2009).
Version 1.14.0. Available online at: http://bioconductor.org
Obermann-Borst, S. A., Eilers, P. H., Tobi, E. W., de Jong, F. H., Slagboom,
P. E., Heijmans, B. T., et al. (2013). Duration of breastfeeding and gender
are associated with methylation of the LEPTIN gene in very young children.
Pediatr. Res. 74, 344–349. doi: 10.1038/pr.2013.95
Popp, C., Dean, W., Feng, S., Cokus, S. J., Andrews, S., Pellegrini, M., et al. (2010).
Genome-wide erasure of DNA methylation in mouse primordial germ cells is
affected by AID deficiency. Nature 463, 1101–1105. doi: 10.1038/nature08829
Radpour, R., Kohler, C., Haghighi, M. M., Fan, A. X., Holzgreve, W., and Zhong,
X. Y. (2009). Methylation profiles of 22 candidate genes in breast cancer
using high-throughput MALDI-TOFmass array.Oncogene 28, 2969–2978. doi:
10.1038/onc.2009.149
R Development Core Team. (2011). R: A Language and Environment for Statistical
Computing. Vienna. Available online at: http://www.R-project.org/
RSeqMeth: Package for analysis of Sequenom EpiTYPER Data [computer
program]. (2008). Version 1.0.2. Available online at: http://bioconductor.org
Tobi, E. W., Goeman, J. J., Monajemi, R., Gu, H., Putter, H., Zhang, Y., et al.
(2014). DNA methylation signatures link prenatal famine exposure to growth
and metabolism. Nat. Commun. 5:5592. doi: 10.1038/ncomms6592
Tobi, E. W., Heijmans, B. T., Kremer, D., Putter, H., Delemarre-van de Waal, H.
A., Finken, M. J., et al. (2011). DNA methylation of IGF2, GNASAS, INSIGF
and LEP and being born small for gestational age. Epigenetics 6, 171–176. doi:
10.4161/epi.6.2.13516
Tobi, E. W., Lumey, L. H., Talens, R. P., Kremer, D., Putter, H., Stein, A. D., et al.
(2009). DNA Methylation differences after exposure to prenatal famine are
common and timing- and sex-specific. Hum. Mol. Genet. 18, 4046–4053. doi:
10.1093/hmg/ddp353
Tobi, E. W., Slagboom, P. E., van Dongen, J., Kremer, D., Stein, A. D., Putter,
H., et al. (2012). Prenatal famine and genetic variation are independently
and additively associated with DNA methylation at regulatory loci within
IGF2/H19. PLoS ONE 7:e37933. doi: 10.1371/journal.pone.0037933
Zeilinger, S., Kühnel, B., Klopp, N., Baurecht, H., Kleinschmidt, A., Gieger,
C., et al. (2013). Tobacco smoking leads to extensive genome-wide changes
in DNA methylation. PLoS ONE 8:e63812. doi: 10.1371/journal.pone.
0063812
Zhang, Y., Yang, R., Burwinkel, B., Breitling, L. P., and Brenner, H. (2014).
F2RL3 methylation as a biomarker of current and lifetime smoking exposures.
Environ. Health Perspect. 122, 131–137. doi: 10.1289/ehp.1306937
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Suchiman, Slieker, Kremer, Slagboom, Heijmans and Tobi. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Genetics | www.frontiersin.org 14 September 2015 | Volume 6 | Article 287
